期刊文献+

高敏感C反应蛋白和淀粉样物质A与冠状动脉病变程度的关系 被引量:4

Relationship between highly sensitive C reactive protein,serum amyloid A and severity of coronary artery disease
在线阅读 下载PDF
导出
摘要 目的 :探讨血浆高敏感 C反应蛋白 (hs- CRP)和淀粉样物质 A(SAA)与冠状动脉病变程度和病变活动性之间的关系。 方法 :分析 94例冠状动脉造影患者的临床资料 ,并采用乳胶增强速率散射比浊法测定患者循环血中 hs- CRP与 SAA水平。 结果 :临床诊断急性冠状动脉综合征患者血浆 hs- CRP和 SAA水平为 (1 6 .34± 1 6 .0 2 )和 (9.4 6± 6 .97) mg/ L ,明显高于正常对照组的 (1 .0 7± 1 .1 2 )和 (1 .2 4± 1 .1 1 ) m g/ L (P<0 .0 1 ) ;稳定型心绞痛组为 (2 .76± 2 .31 )和 (2 .85± 2 .1 3) mg/ L ,与对照组间无显著性差异 ;中、重度病变 ,单支、双支、三支病变及 Gensini积分 2 1~ 4 0分者 hs- CRP和 SAA水平明显高于对照组(P<0 .0 5 ,P<0 .0 1 )。结论 :冠心病的发生、发展过程中存在炎症反应 ;血浆 hs- CRP和 SAA水平可作为炎症标志物反映冠状动脉炎症状况 。 Objective:To study the relationship among high-sensitivity C-reactive protein,serum amyloid A and the severity of coronary lesions.Methods:We studied the data of coronary angiography in94patients and measured their plasma concentrations of high-sensitivity C-reactive protein(hs-CRP)and serum amyloid A with an immunophelometric assay.Re-sults:Plasma concentrations of hs-CRP and serum amyloid A were significantly raised in acute coronary syndrome [(16.34±16.02)mg/L and(9.46±6.97)mg/L]compared with stable angina pectoris group [(2.76±2.31)mg/L and(2.85±2.13) mg/L](P<0.01)and normal controls [(1.07±1.12)mg/L and(1.24±1.11)mg/L](P<0.01).There was no signifi-cant difference between the latter2groups.Plasma concentrations of hs-CRP and serum amyloid A were significantly higher in patients with moderate to severe lesions,with single,double and3branches lesions,and with Gensini score being21-40than those in control groups(P<0.05,P<0.01).Conclusion:Inflammation is associated with coronary artery disease pro-gression.The levels of hs-CRP and serum amyloid A may reflect inflammatory activity of atherosclerotic diseases,which has diagnosis value for the acute coronary syndrome.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2004年第7期763-765,共3页 Academic Journal of Second Military Medical University
关键词 冠状动脉疾病 炎症 高敏感C反应蛋白 淀粉样物质A coronary disease inflammation high-sensitivity C-reactive protein serum amyloid A
  • 相关文献

参考文献7

  • 1Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol,1983,51(3):606.
  • 2Ross R. Ateriosclerosis is an inflammatory disease[J]. Am Heart J,1999,138(5 Pt 2): S419-S420.
  • 3Tataru MC, Heinrich J, Junker R, et al. C-reactive protein and the severity of ateriosclerosis in myocardial infarction patients with stable angina pectoris[J]. Eur Heart J, 2000,21(12):1000-1008.
  • 4Delanghe JR, Langlosi MR, De Bacquer D, et al. Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease[J]. Atherosclerosis, 2002,160(2):471-476.
  • 5Lind L. Circulating markers of inflammation and atherosclerosis[J]. Atherosclerosis, 2003,169(2):203-214.
  • 6Katayama T, Nakashima H, Yonekura T, et al. Significance of acute-phase inflammatory reactants as an indicator of prognosis after acute myocardial infarction: which is the most useful predictor[J].J Cardiol,2003,42(2):49-56.
  • 7Nijmeijer R, Lagrand WK, Lubbers YT, et al. C-reactive protein activates complement in infarcted human myocardium[J]. Am J Pathol, 2003,163(1):269-275.

共引文献2

同被引文献55

  • 1王旋,程龙献,崔天盆,张红梅,何美安,廖玉华,邬堂春.血清淀粉样蛋白A与冠心病及冠心病危险因素的关系[J].临床心血管病杂志,2004,20(12):745-747. 被引量:15
  • 2Katan M,Morgenthaler N G,Dixit K C,Rutishauser J,Brabant G E,Muller B, et al. Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay[J]. J Clin Endocrinol Metab, 2007, 92: 2640- 2643.
  • 3Szinnai G, Morgenthaler N G, Berneis K, Struck J, Mailer B, Keller U,et al. Changes in plasma copeptin,the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects[J]. J Clin Endocrinol Metab,2007,92: 3973-3978.
  • 4Tolg R, Witt M, Schwarz B, Kurz T, Kurowski V, Hartmann F,et al. Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention-the PASSAT Study[J]. Clin Res Cardiol, 2006, 95:31-41.
  • 5Khan S Q,Dhillon O S,O'Brien R J,Struck J,Quinn P A,Morgenthaler N G,et al. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study [J]. Circulation, 2007,115:2103-2110.
  • 6Gensini G G. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol, 1983,51:606.
  • 7Babar S I,Berg R A, Hilwig R W,Kern K B,Ewy G A. Vasopressin versus epinephrine during cardiopulmonary resuscitation: a randomized swine outcome study[J]. Resuscitation, 1999,41:185-192.
  • 8Voelckel W G, Lurie K G, McKnite S, Zielinski T, Lindstrom P,Peterson C,et al. Effects of epinephrine and vasopressin in a piglet model of prolonged ventricular fibrillation and cardiopulmonary resuscitation[J]. Crit Care Med, 2002,30 : 957-962.
  • 9Wenzel V,Lindner K H,Mayer H,Lurie K G,Prengel A W. Vasopressin combined with nitroglycerin increases endocardial perfusion during cardiopulmonary resuscitation in pigs[J]. Resuscitation, 1998,38 : 13-17.
  • 10Cowley A W Jr, Merrill D, Osborn J, Barber B J. Influence of vasopressin and angiotensin on baroreflexes in the dog[J]. Circ Res,1984,54:163-172.

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部